Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
9.74
+0.19 (1.99%)
At close: Jun 10, 2025, 4:00 PM
9.86
+0.12 (1.23%)
After-hours: Jun 10, 2025, 4:47 PM EDT
Xencor Market Cap
Xencor has a market cap or net worth of $693.20 million as of June 10, 2025. Its market cap has decreased by -52.70% in one year.
Market Cap
693.20M
Enterprise Value
173.03M
1-Year Change
-52.70%
Ranking
Category
Stock Price
$9.74
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $693.20M, an increase of 182.48%. That is a compound annual growth rate of 9.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 686.80M | -57.29% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |